Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3991294 | 0.91 | CA4 (0.32) | CA4 | |
| SCHEMBL7743009 | 0.87 | — | — | |
| SCHEMBL28765732 | 0.85 | — | — | |
| SCHEMBL229478 | 0.85 | FDPS (0.39) | CA4 | |
| SCHEMBL27438 | 0.83 | — | — | |
| SCHEMBL27687490 | 0.82 | — | — | |
| SCHEMBL122713 | 0.82 | FDPS (0.36) | CA4 | |
| SCHEMBL20239668 | 0.82 | — | — | |
| SCHEMBL17061103 | 0.81 | CA4 (0.36) | CA4 | |
| Hydrochloric Acid SCHEMBL1803055 | 0.81 | CA4 (0.36) | CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080265223-A1 | Fire-retardant compositions and methods of making and using same | OSMOSE, INC. | 2008-10-30 | — | — | US | claimed |
| JP-61050499-A | — | — | None | — | — | JP | disclosed |
| JP-61050500-A | — | — | None | — | — | JP | disclosed |
| CN-109963885-B | Guanidine diphosphate and guanidine polyphosphate ligands and group IV metal catalysts produced therefrom | 陶氏环球技术有限责任公司 | 2022-06-14 | — | — | CN | disclosed |
| US-11246873-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2022-02-15 | — | — | US | disclosed |
| US-20200390780-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) | 2020-12-17 | — | — | US | disclosed |
| US-10660899-B2 | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-05-26 | — | — | US | disclosed |
| WO-2019031859-A1 | WOOD/INORGANIC LAMINATE COMPOSITE MATERIAL | 전북대학교 산학협력단 | 2019-02-14 | — | — | WO | disclosed |
| US-9669564-B2 | Methods of conferring fire retardancy to wood and fire-retardant wood products | KOPPERS PERFORMANCE CHEMICALS INC. (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170136029-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | IRM LLC (BM) | 2017-05-18 | — | — | US | disclosed |
| EP-2704566-A1 | A METHOD FOR ENHANCING THE PERFORMANCE OF A PESTICIDE WITH GUANIDINES | BASF SE (DE) | 2014-03-12 | — | — | EP | disclosed |
| US-20140066309-A1 | Method for Enhancing the Performance of a Pesticide with Guanidines | BASF SE (DE) | 2014-03-06 | — | — | US | disclosed |
| US-20140038949-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | IRM LLC (BM) | 2014-02-06 | — | — | US | disclosed |
| EP-2675893-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | The Scripps Research Institute (US) | 2013-12-25 | — | — | EP | disclosed |
| WO-2012150162-A1 | A METHOD FOR ENHANCING THE PERFORMANCE OF A PESTICIDE WITH GUANIDINES | BASF SE (DE) | 2012-11-08 | — | — | WO | disclosed |
| WO-2012112933-A1 | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-08-23 | — | — | WO | disclosed |
| US-20080265223-A1 | Fire-retardant compositions and methods of making and using same | OSMOSE, INC. | 2008-10-30 | — | — | US | disclosed |
| CN-1061974-C | Process for synthesis of guanidine dihydrogen phosphate and guanidine hydrogen phosphate | UNIV DONGBEI FORESTRY (CN) | 2001-02-14 | — | — | CN | disclosed |
| JP-S6150499-A | VOICE COIL BOBBIN FOR SPEAKER | PIONEER ELECTRONIC CORP | 1986-03-12 | — | — | JP | disclosed |
| JP-S6150500-A | ROLLED PAPER USED FOR VOICE COIL BOBBIN FOR SPEAKER | PIONEER ELECTRONIC CORP | 1986-03-12 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140066309-A1 | Method for Enhancing the Performance of a Pesticide with Guanidines | ACHE, GDA, DDT | CA4 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.